谷物
发表于 2025-3-25 04:59:36
http://reply.papertrans.cn/47/4629/462875/462875_21.png
fibroblast
发表于 2025-3-25 08:45:40
http://reply.papertrans.cn/47/4629/462875/462875_22.png
只有
发表于 2025-3-25 13:14:09
http://reply.papertrans.cn/47/4629/462875/462875_23.png
Flawless
发表于 2025-3-25 19:16:55
http://reply.papertrans.cn/47/4629/462875/462875_24.png
赦免
发表于 2025-3-25 23:38:20
http://reply.papertrans.cn/47/4629/462875/462875_25.png
厨师
发表于 2025-3-26 02:38:36
http://reply.papertrans.cn/47/4629/462875/462875_26.png
formula
发表于 2025-3-26 07:04:30
http://reply.papertrans.cn/47/4629/462875/462875_27.png
重叠
发表于 2025-3-26 09:59:30
http://reply.papertrans.cn/47/4629/462875/462875_28.png
极力证明
发表于 2025-3-26 14:12:12
http://reply.papertrans.cn/47/4629/462875/462875_29.png
不如乐死去
发表于 2025-3-26 16:55:41
Hans Georg Möllery targets. Bioinformatic tools are classifying candidate drug targets into different mechanistic classes. Many classes are apparent, but pharmaceutical companies are clearly focusing on proteases, protein kinases, and G-protein coupled receptors (GPCRs). This is perhaps because of the relatively dir